Growth Metrics

Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Organogenesis Holdings (ORGO) has 5 years of Non-Current Deffered Revenue data on record, last reported at $1.1 million in Q3 2020.

  • For Q3 2020, Non-Current Deffered Revenue rose 49.18% year-over-year to $1.1 million; the TTM value through Sep 2020 reached $1.1 million, up 49.18%, while the annual FY2019 figure was $1.0 million, 678.46% up from the prior year.
  • Non-Current Deffered Revenue reached $1.1 million in Q3 2020 per ORGO's latest filing, roughly flat from $1.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $10.8 million in Q4 2016 and bottomed at $74000.0 in Q4 2017.
  • Average Non-Current Deffered Revenue over 5 years is $4.8 million, with a median of $1.1 million recorded in 2020.
  • Peak YoY movement for Non-Current Deffered Revenue: crashed 99.32% in 2017, then soared 678.46% in 2019.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $10.8 million in 2016, then plummeted by 99.32% to $74000.0 in 2017, then surged by 75.68% to $130000.0 in 2018, then skyrocketed by 678.46% to $1.0 million in 2019, then increased by 8.5% to $1.1 million in 2020.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $1.1 million in Q3 2020, $1.1 million in Q2 2020, and $1.1 million in Q1 2020.